Visiting Professor, Biostatistics
N/A
School of Dentistry
Visiting Professor
|
Qualification |
Year |
Awarding Institution |
Department |
Thesis title (Optional Entry) |
|
Bachelor of Science in Physics |
1990 |
Aristotle University of Thessalonica, Greece |
Department of Physics |
|
|
Master of Science in Molecular Biology |
1994 |
University of Crete, Greece |
Department of Biology |
|
|
Doctor of Philosophy |
2002 |
National and Kapodistrian University of Athens, Greece |
School of Medicine |
Molecular epidemiology of HIV-1 infection in Greece |
|
Period of employment |
Employer |
Location |
Position |
|
|
From |
To |
|||
|
2024 |
present |
European University Cyprus |
Cyprus |
Visiting Professor, Biostatistics |
|
February 2023 |
present |
National and Kapodistrian University of Athens |
Athens |
Professor of Epidemiology & Preventive Medicine |
|
February 2019 |
January 2023 |
National and Kapodistrian University of Athens |
Athens |
Associate Professor of Epidemiology & Preventive Medicine |
|
2016 |
2023 |
European University Cyprus |
Cyprus |
Scientific Collaborator, Epidemiology – Research methodology |
|
July 2014 |
January 2019 |
National and Kapodistrian University of Athens |
Athens |
Assistant Professor of Epidemiology & Preventive Medicine |
|
May 2009 |
June 2014 |
National and Kapodistrian University of Athens |
Athens |
Lecturer of Epidemiology & Preventive Medicine |
|
February 2004 |
April 2009 |
National and Kapodistrian University of Athens |
Athens |
Senior Researcher |
|
January 1996 |
January 2004 |
National and Kapodistrian University of Athens |
Athens |
Researcher |
|
Ref. Number |
Year |
Title |
Other authors |
Journal and Publisher / |
Vol. |
Pages |
|
1 |
2025 |
Diagnostic accuracy of an artificial intelligence-based software in detecting supernumerary and congenitally missing teeth in panoramic radiographs. |
Makrygiannakis MA, Giannakopoulos K, Kavadella A, Paraskevis D, Kaklamanos EG |
Eur J Orthod |
47 |
|
|
2 |
2024 |
Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study |
Bournia VK, Fragoulis GE, Mitrou P, Tsolakidis A, Mathioudakis K, Vassilopoulos D, Tektonidou M, Paraskevis D, Sfikakis PP |
Rheumatol Int |
44 |
2837-2846 |
|
3 |
2023 |
Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk |
Paraskevis D, Gkova M, Mellou K, Gerolymatos G, Psalida N, Gkolfinopoulou K, Kostaki EG, Loukides S, Kotanidou A, Skoutelis A, Thiraios E, Saroglou G, Zografopoulos D, Filippou D, Mossialos E, Zaoutis T, Gaga M, Tsiodras S, Antoniadou A |
J Infect Dis |
228 |
1667-1674 |
|
4 |
2023 |
Influenza transmission during COVID-19 measures downscaling in Greece, August 2022: evidence for the need of continuous integrated surveillance of respiratory viruses |
Mellou K, Tryfinopoulou K, Emmanouil M, Gkolfinopoulou K, Sapounas S, Evangelidou M, Moulopoulou P, Miaoulis E, Angelakis E, Sourvinos G, Zaoutis T, Paraskevis D |
Euro Surveill |
24 |
|
|
5 |
2023 |
Stimulating dissemination of research that addresses the social and contextual drivers of HIV prevention and treatment in the journal AIDS |
Schneider J, Coutinho R, Hatcher AM, Larmarange J, Letendre S, Paraskevis D, Strathdee S, Vance DE, Martínez E |
AIDS |
37 |
|
|
6 |
2022 |
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors |
Kostaki EG, Limnaios S, Adamis G, Xylomenos G, Chini M, Mangafas N, Lazanas M, Patrinos S, Metallidis S, Tsachouridou O, Papastamopoulos V, Chatzidimitriou D, Antoniadou A, Papadopoulos A, Protopapas K, Tsiara C, Psichogiou M, Basoulis D, Pilalas D, Paraskeva D, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Bolanos V, Sipsas NV, Lada M, Barbounakis E, Kantzilaki E, Panagopoulos P, Petrakis V, Drimis S, Katsarolis I, Lagiou P, Hatzakis A, Magiorkinis G, Skoura L, Paraskevis D |
HIV Med |
11 |
1143-1152 |
|
7 |
|
|
|
|
|
|
|
8 |
2021 |
Efficient and targeted COVID-19 border testing via reinforcement learning |
Bastani H, Drakopoulos K, Gupta V, Vlachogiannis I, Hadjichristodoulou C, Lagiou P, Magiorkinis G, Paraskevis D, Tsiodras S |
Nature |
599 |
108-113 |
|
9 |
2017 |
Molecular Tracing of the Geographical Origin of Human Immunodeficiency Virus Type 1 Infection and Patterns of Epidemic Spread Among Migrants Who Inject Drugs in Athens |
Paraskevis D, Kostaki E, Nikolopoulos GK, Sypsa V, Psichogiou M, Del Amo J, Hodges-Mameletzis I, Paraskeva D, Skoutelis A, Malliori M, Williams L, Friedman SR, Daikos GL, Hatzakis A |
Clin Infect Dis |
65 |
2078-2084 |
|
10 |
2013 |
Dating the origin and dispersal of hepatitis B virus infection in humans and primates |
Paraskevis D, Magiorkinis G, Magiorkinis E, Ho SY, Belshaw R, Allain JP, Hatzakis A |
Hepatology |
57 |
908-16 |
|
Ref. Number |
Date |
Topic |
International / Local |
Location* |
Role in Exhibition |
|
1 |
2025 |
23rd European Meeting on HIV & Hepatitis |
International |
Barcelona |
Chair of Round Table discussions |
|
2 |
2021 |
19th European Meeting on HIV & Hepatitis |
International |
Virtual |
Chair of Round Table discussions |
|
3 |
2020 |
18th European Meeting on HIV & Hepatitis |
International |
Virtual |
Chair of Round Table discussions |
|
4 |
2019 |
17th European Meeting on HIV & Hepatitis |
International |
Rome |
Chair of Round Table discussions |
|
5 |
2018 |
16th European Meeting on HIV & Hepatitis |
International |
Rome |
Chair of Round Table discussions |
|
6 |
2003-2025 |
National AIDS Conference |
Local |
Athens |
Chair of Round Table discussions |
|
Ref. Number |
Date |
Title |
Funded by |
Project Role* |
|
1 |
2024-2025 |
Study of the prevalence and transmission patterns of HIV resistance in Europe |
Gilead Sciences |
Primary Investigator |
|
2 |
2024-2025 |
Real-world effectiveness of nirmatrelvir/ritonavir among patients at high-risk for severe COVID-19 in Greece |
Pfizer |
Primary Investigator |
|
3 |
2019-2020 |
Investigation of the HIV and Hepatitis C epidemic among people who inject drugs in Greece and estimation of the most effective public measures by using mathematical modeling and molecular epidemiology |
NSRF Development Programming |
co-PI in collaboration with Vana Sypsa |
|
4 |
2019-2022 |
ALEXANDROS” (Diagnosis and linkage to care of HIV and HCV infected cases among people who inject drugs in Thessalonica) |
CHIME funding program from Gilead Sciences |
Coordinator for molecular epidemiology studies |
|
5 |
2017-2019 |
“ARISTOTLE HCV & HIV” (Diagnosis and linkage to care of HIV and HCV infected cases among people who inject drugs in Athens) |
COMMIT funding program from Gilead Sciences Europe and AbbVie |
Coordinator for molecular epidemiology studies |
|
6 |
2017-2018 |
“Hepatitis C, Hepatitis B HIV and Tuberculosis among incarcerated people in Greece” |
Gilead Sciences Europe and AbbVie |
Coordinator for molecular epidemiology studies |
|
7 |
2015-2017 |
“Sophocles – P4G”, funded by NIH, National Institute of Allergy and Infectious Diseases |
NIH |
Coordinator for molecular epidemiology studies |
|
8 |
2015-2018 |
“Athens MSM network intervention project” |
NIH |
Coordinator for molecular epidemiology studies |
|
9 |
2014-2015 |
Development and assessment of novel intrapatient viral replication diversity markers for Human Immunodeficiency Virus and Hepatitis C Virus infections using next generation sequencing method |
NSRF Development Programming |
Primary Investigator |
|
10 |
2012-2014 |
ARISTOTLE programme a seek-test-treat-retain (STTR) intervention to decrease HIV/AIDS transmission among IDUs IN Athens metropolitan area |
NSRF Development Programming |
Co-PI in collaboration with Vana sypsa and Angelos Hatzakis |
|
Ref. Number |
Period |
Organization |
Title of Position or Service |
Key Activities |
|
1 |
2025-2026 |
EU Health Task Force (EUHTF) Advisory Group for Supporting Emergency and Response in EU and globally (ECDC) |
Independent Top-Level Specialists |
The EUHTF provides rapid, expert advice and operational recommendations to the European Commission and EU member states to prepare for and respond to serious cross-border health threat |
|
2 |
2022-present |
National Public Health Organization |
Member of the Board of Directors |
Strategic governance, planning, and direction, operational oversight and performance, supervision of executive leadership, and external advocacy |
|
3 |
2021-present |
Committee of Public Health of the Ministry of Health |
Member of the Committee |
The National Committee of Public Health act as key scientific advisor to the Minister of Health and other government bodies |
|
4 |
2020-present |
Ministry of Health |
Member of the Committee |
Scientific advisor to Minister of Health and other government bodies for the management of covid-19 pandemic in Greece |
|
5 |
2022-present |
Bioethics Committee of the National Public Health Organization (NPHO) |
Coordinator |
Ethical Review and Oversight of Research and Guidance on Public Health Policies and Interventions |
|
6 |
2023-present |
Committee for the newsletter of the National Public Health Organization (NPHO) |
Scientific coordinator |
Scientific coordinator of the newsletter |
|
Ref. Number |
Date |
Title |
Awarded by: |
|
1 |
2021 |
Efficient and targeted COVID-19 border testing via reinforcement learning |
Pierskalla Best Paper Award for research excellence in the field of healthcare management |
|
2 |
2021 |
Humanitarian award: «Pro Bono Humanum” as a member of the national taskforce against covid-19 |
Prix Galien Greece 2021 |
|
3 |
2018 |
Timely intervention among people who inject drugs and their high risk contacts for the control of HIV/AIDS outbreak in Athens – ARISTOTLE project |
WHO/Regional Office for Europe |
|
4 |
2016 |
EMCDDA scientific award 2016 among 50 other scientific publications Title of study: Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme |
European Monitoring Centre for Drugs and Drug Addiction EMCDDA |
|
5 |
|
Best poste award Title: HIV-1 Local Transmission Networks in 9 European Countries and Canada:Association with Demographic and Clinical Factors |
15th European AIDS Conference (EACS) |
|
Ref. Number |
Date |
Title |
Key Activities: |
|
1 |
2020-present |
Consultant at the Infectious Disease, Epidemiology and Socio-behavioral Theory Core (IDEST) for the Center named: REINVIGORATING HIV PREVENTION AND CARE FOR PEOPLE WHO USE DRUGS”, Center for drug use and HIV/ HCV Research, New York, USA |
Scientific consultant |
|
2 |
2019-present |
Member of the organizing committee for the European Meeting on HIV & Hepatitis 2025 |
Scientific programming and content development, strategic planning and oversight |
|
3 |
2023-present |
Editorial board member of AIDS journal |
Handling editor |
|
4 |
2022-present |
Editorial board member of Eurosurveillance journal |
Handling editor |
|
5 |
2021 |
Co-editor for the special issue of the Viruses Journal entitled “HIV Molecular epidemiology for prevention” |
Handling editor |
|
6 |
2019-2020 |
eLife community ambassador |
Community engagement, advocacy, and facilitating the transition to open science |
|
7 |
2019 |
Chair of the Scientific committee of the National AIDS Conference |
Coordinating the scientific committee – defining the scientific programme |
|
8 |
2018-2019 |
Member of the Scientific Committee of the European AIDS Clinical Society (EACS) Conference 2019 |
Defining the scientific programme |
|
9 |
2016-2025 |
Editorial board member for mbio journal |
Handling editor |
|
10 |
2015-present |
Editorial board member for Molecular Phylogenetics and evolution journal |
Handling editor |